tirzepatide and intermittent fasting on Tirzepatide: Safety & Effectiveness Intermittent fasting (5:2) more effective

People who took semaglutide lost an average of 14.9% of their body weight, while those who took the placebo lost only 2.4%

doi: 10.1177/03000605231164548 54 RitchieRHAbelED

Related Reading Frequently Asked Questions What is retatrutide and how is it different from semaglutide or tirzepatide

This decision should be made with your healthcare provider

Jagomae T, Seppa K, Reimets R et al (2021) Early intervention and lifelong treatment with GLP1 receptor agonist liraglutide in a wolfram syndrome rat model with an emphasis on visual neurodegeneration, sensorineural hearing loss and diabetic phenotype

GLP-1 also has a role in signalling the brains appetite regulation centres, signaling satiety